Mercedes E. Gonzalez, MD

Medical Director
Pediatric Skin Research, LLC

Poster(s):

• (102) Caregiver-reported outcomes from the phase 3 INTEGUMENT-PED trial of children aged 2–5 years with atopic dermatitis and treated with roflumilast cream 0.05%
  Wednesday, October 29, 2025